A compound of formula wherein: X is CR 0 or N, i.e. forms together with the ring to which it belongs respectively a benzene or a pyridine group, R 0, R 1, R 2, R 3, R 4, R 7 and R 8 independently represent a hydrogen atom, a halogen atom or a group chosen among a (C 1 -C 5)alkyl group, a (C 3 -C 6)cycloalkyl group, a (C 1 -C 5)fluoroalkyl group, a (C 1 -C 5)alkoxy group, a (C 1 -C 5)fluoroalkoxy group, a -CN group, a -COOR a group, a -NO 2 group, a -NR a R b group, a -NR a- SO 2- NR a R b group, a -NR a- SO 2- R a group, a -NR a -C(=O)-R a group, a -NR a -C(=O)-NR a R b group, a -SO 2- NR a R b group, a -SO 3 H group, a -OH group, a -O-SO 2 -OR c group, a -O-P(=O)-(OR c)(OR d) group, a -O-CH 2 -COOR c group and can further be a group chosen among: A is a covalent bond, an oxygen atom or NH, B is a covalent bond or NH, n is 1, 2, 3, 4 or 5, m is 1, 2 or 3, R, R', R a and R b independently represent a hydrogen atom, a (C 1- C 5)alkyl group or a (C 3 -C 6)cycloalkyl group, R and R' can further form together with the nitrogen atom to which they are attached a saturated 5- or 6-membered heterocycle optionally containing a further heteroatom chosen among N, O and S, said heterocycle being optionally substituted by one or more R, R c and R d independently represent a hydrogen atom, Li +, Na +, K +, N + (R a) 4 or a benzyl group, R 5 represents a hydrogen atom, a (C 1 -C 5)alkyl group or a (C 3 -C 6)cycloalkyl group, R 10 is a hydrogen atom or a chlorine atom, and R 11 is a hydrogen atom or a (C 1 -C 4)alkyl group or anyone of its pharmaceutically acceptable salts, provided that at least three of R 5, R 7, R 8 and R 10 are different from a hydrogen atom, or alternatively provided that one of R 7 and R 8 is a group chosen among a -NR a -SO 2 -NR a R b group, a -NRa-SO 2- R a group, a -NR a -C(=O)-R a group and a -NR a -C(=O)-NR a R b group wherein R, R', A, B, R a, R b, n and m are as defined above, and the other of R 7 and R 8 is a hydrogen atom, or alternatively provided that one of R 0, R 1, R 2, R 3 and R 4 is a group chosen among -NR a -SO 2 -NR a R b group, a -NR a -SO 2 -R a group, a -NR a -C(=O)-R a group and a -NR a -C(=O)-NR a R b group wherein R, R', A, B, R a, R b, n and m are as defined above, for use as in a method of preventing, inhibiting or treating AIDS. X is CR 0 or N, i.e. forms together with the ring to which it belongs respectively a benzene or a pyridine group, R 0, R 1, R 2, R 3, R 4, R 7 and R 8 independently represent a hydrogen atom, a halogen atom or a group chosen among a (C 1 -C 5)alkyl group, a (C 3 -C 6)cycloalkyl group, a (C 1 -C 5)fluoroalkyl group, a (C 1 -C 5)alkoxy group, a (C 1 -C 5)fluoroalkoxy group, a -CN group, a -COOR a group, a -NO 2 group, a -NR a R b group, a -NR a- SO 2- NR a R b group, a -NR a- SO 2- R a group, a -NR a -C(=O)-R a group, a -NR a -C(=O)-NR a R b group, a -SO 2- NR a R b group, a -SO 3 H group, a -OH group, a -O-SO 2 -OR c group, a -O-P(=O)-(OR c)(OR d) group, a -O-CH 2 -COOR c group and can further be a group chosen among: A is a covalent bond, an oxygen atom or NH, B is a covalent bond or NH, n is 1, 2, 3, 4 or 5, m is 1, 2 or 3, R, R', R a and R b independently represent a hydrogen atom, a (C 1- C 5)alkyl group or a (C 3 -C 6)cycloalkyl group, R and R' can further form together with the nitrogen atom to which they are attached a saturated 5- or 6-membered heterocycle optionally containing a further heteroatom chosen among N, O and S, said heterocycle being optionally substituted by one or more R, R c and R d independently represent a hydrogen atom, Li +, Na +, K +, N + (R a) 4 or a benzyl group, R 5 represents a hydrogen atom, a (C 1 -C 5)alkyl group or a (C 3 -C 6)cycloalkyl group, R 10 is a hydrogen atom or a chlorine atom, and R 11 is a hydrogen atom or a (C 1 -C 4)alkyl group or anyone of its pharmaceutically acceptable salts, provided that at least three of R 5, R 7, R 8 and R 10 are different from a hydrogen atom, or alternatively provided that one of R 7 and R 8 is a group chosen among a -NR a -SO 2 -NR a R b group, a -NRa-SO 2- R a group, a -NR a -C(=O)-R a group and a -NR a -C(=O)-NR a R b group wherein R, R', A, B, R a, R b, n and m are as defined above, and the other of R 7 and R 8 is a hydrogen atom, or alternatively provided that one of R 0, R 1, R 2, R 3 and R 4 is a group chosen among -NR a -SO 2 -NR a R b group, a -NR a -SO 2 -R a group, a -NR a -C(=O)-R a group and a -NR a -C(=O)-NR a R b group wherein R, R', A, B, R a, R b, n and m are as defined above, for use as in a method of preventing, inhibiting or treating AIDS.